2h
Hosted on MSNModerna Reports 2024 Loss, Eyes Future GrowthModerna ( ($MRNA) ) has released its Q4 earnings. Here is a breakdown of the information Moderna presented to its investors. Moderna, Inc. is a ...
Vistagen Therapeutics, Inc.'s fasedienol shows promise in treating social anxiety; new results expected 2025. Click for my ...
All high schools, including Elliot Alternative, offer the design, visual and media arts pathway. Davis, Downey, Gregori and ...
17h
Hosted on MSNEU reshapes HTAs: is the industry ready for it?New EU regulations aim to speed up health technology assessments (HTAs), but the pharma industry raises logistical concerns.
Speaking this week at BIO CEO, the heads of Septerna, Upstream Bio and Actuate Therapeutics shared lessons from going public ...
The Crimson spoke to a range of commercial realtors, startup founders, and a commercial lab space owner to understand how the immense draw of Kendall Square has forced the myriad startup companies ...
Encoded’s layoffs will mostly affect its technology and early-stage research and development functions. The move is expected ...
Latent Labs has raised $50 million of new funding as it commercialises its GenAI technology for designing new proteins for ...
Discover seven companies operating in metabolomics, the field that could significantly boost precision medicine.
Isomorphic Labs, a spin-off from DeepMind, is applying AI-first principles to drug discovery rather than just protein ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results